The heat shock response is an evolutionarily conserved response to heat and other stresses that promotes the maintenance of key metabolic functions and cell survival. We report that exposure of human prostate (DU-145) and breast (MCF-7) cancer cells to heat (421C) caused a rapid disappearance of the breast cancer susceptibility gene-1 (BRCA1) protein, starting at E1 h after the onset of heating and slightly lagging behind the increase in heat shock protein 70 (HSP70) levels. The heat-induced loss of BRCA1 occurred at the protein level, since: (1) BRCA1 mRNA expression was unaffected; and (2) the BRCA1 protein loss was also observed in DU-145 cells that expressed exogenous wild-type BRCA1 (wtBRCA1). In addition to heat regulation of BRCA1 protein levels, we also found that BRCA1 could modulate the heat shock response. Thus, wtBRCA1 overexpressing DU-145 cell clones showed significantly decreased sensitivity to heatinduced cytotoxicity; and Brca1 mutant mouse embryo fibroblasts showed increased sensitivity to heat. The DU-145 wtBRCA1 clones also showed increased expression of the small heat shock protein HSP27; and reporter assays revealed that wtBRCA1 stimulated a two to four-fold increase in HSP27 promoter activity, consistent with its ability to upregulate HSP27 mRNA and protein levels. In studies using epitope-tagged truncated BRCA1 proteins, the ability to stimulate the HSP27 promoter and to mediate heat-induced degradation required the aminoterminus but not the carboxyl-terminus of BRCA1. Although the heat-induced loss of BRCA1 appeared to be due to protein degradation, various protein metabolic agents (or combinations) failed to block this event, including: MG132 (a 26S proteasomal inhibitor), Nacetyl-leucyl-leucyl-norleucinal (a calpain inhibitor), z-VAD-fmk (a pan-caspase inhibitor), and ammonium chloride and chloroquine (which stabilize lysosomes). These findings suggest that in addition to its other functions, BRCA1 may participate in mammalian heat shock response pathways.
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Introduction
The heat shock response is a highly conserved mechanism that protects cells against thermal and other environmental stresses, in part, by preserving the structural integrity of key cellular regulatory proteins (Jolly and Morimoto, 2000) . Various classes of heat shock proteins (HSPs) protect and maintain cellular regulatory proteins by binding to them and functioning as molecular 'chaperones' to prevent their mis-folding or to stabilize the active configuration of the protein. By these mechanisms, HSPs may function in a variety of molecular pathways, including signal transduction, transcriptional regulation, and regulation of various enzymatic activities. For example, direct interactions of HSP90 with c-Akt (protein kinase B), steroid hormone receptors, and TERT (the catalytic subunit of the telomerase holoenzyme) can modulate the functional activities of these proteins (Sato et al., 2000; Forsythe et al., 2001) .
Recently, various studies have implicated HSPs (HSP70, HSP27, and HSP90) in the regulation of apoptosis signaling pathways (Guenal et al., 1997; Jaattela et al., 1998; Garrido et al., 1999; Nylandsted et al., 2000b; Pandey et al., 2000; Saleh et al., 2000; Kamradt et al., 2001) . In the setting of apoptosisinducing cellular stresses, these HSPs often (Garrido et al., 1999; Garrido et al., 1999; Saleh et al., 2000) , but not invariably, function postmitochondrially, by blocking the formation and/or activity of the 'aposome'. The latter is a high molecular weight oligomeric protein complex, containing cytochrome c, apoptosis inducing factor-1 (Apaf-1), and pro-caspase-9 (Caspases: cysteine aspartyl proteases). As a result, pro-caspase-9 is not activated, caspase-9 fails to activate caspase-3, and apoptosis is blocked. Although a precise role has not been established, recent studies suggest that several HSPs (eg., HSP27, HSP70, and HSP90) may play roles in cancer progression (Bubendorf et al., 1999; Cornford et al., 2000; Creagh et al., 2000; Nylandsted et al., 2000a) . For example, HSP27 may be linked to hormone refractory prostate cancers (Bubendorf et al., 1999) . The heat shock response, including the transcription of some of the Hsps (e.g., HSP70), is mediated, in part, by the activation of one or more of the heat shock transcription factors (e.g., HSF-1, -2, -3, and -4), through mechanisms that are, as yet, not clear (Newton et al., 1996; Pirkkala et al., 2001) .
Mutations of the breast cancer susceptibility gene-1 (BRCA1) have been linked to the development of breast, ovarian, and prostatic cancers (Ford et al., 1994; Streuwing et al., 1997; Miki et al., 1994) . Although the precise mechanism(s) by which BRCA1 suppresses tumor formation are unclear, BRCA1 has been implicated in the regulation of a variety of crucial processes, embryonic cell proliferation (Hakem et al., 1996) , cell cycle progression (Chen et al., 1996; Somasundaram et al., 1997) , apoptosis (Shao et al., 1996; Fan et al., 1998b) , DNA damage signaling and repair (Gowen et al., 1998; Moynahan et al., 1999; Lee et al., 2000) , maintenance of genomic stability (Tirkkonen et al., 1997) , and a number of transcriptional pathways (Scully et al., 1997a; Wang et al., 1998; Yu et al., 1998; Zhang et al., 1998; Yarden and Brody, 1999; Jin et al., 2000; Gao et al., 2001; Fan et al., 1999a) . The latter include the regulation of transcriptional pathways mediated by c-Myc, p53, transcriptional repressor complexes (e.g., retinoblastoma (Rb)-histone deacetylases, carboxyl-terminal binding protein (CtBP)), steroid hormone receptors (e.g., estrogen receptor-a), Jak-Stat pathways, and others. It remains to be determined which of these activities of BRCA1 are(is) essential for the suppression of tumor formation.
A role for BRCA1 in the cellular response to heat shock has previously not been established. This study was undertaken to determine if BRCA1 is altered by and/or plays a functional role during the heat shock response.
Results

Disappearance of BRCA1 protein during the heat shock response
Human prostate (DU-145) and breast (MCF-7) cancer cell lines were exposed to heat treatment (at 421C) for various times from T ¼ 1 to 8 h and then harvested for Western blot analyses. As shown in Figure. 1a and b, Figure 1 Loss of BRCA1 protein during heat shock in prostate and breast cancer cells. Subconfluent proliferating cells were exposed to heating at 421C for different times from T ¼ 1 to 8 h and then harvested for protein analyses. Western blotting was performed to detected BRCA1, several HSPs (HSP70 and HSP27), p53, p21
, and a-actin. Western blots for DU-145 human prostate cancer cells and MCF-7 human breast cancer cells are shown in panels a and b, respectively. Panel c shows protein quantitation by densitometry analysis. Protein values are expressed relative to the a-actin band, as a control for loading and transfer. Note: DU-145 cells contain a double point mutant p53. The three p53 bands in panel a represent different post-translationally modified forms of p53 BRCA1 modulates the heat shock response Y Xian et al both cell lines showed a significant loss of the BRCA1 protein by T ¼ 2 h and thereafter. The level of BRCA1 protein (relative to a-actin as a control for loading and transfer) ultimately reaches less than 20% of the unheated control value. Concommitant with the loss of BRCA1, there was an increase in the levels of the heat shock protein HSP70. There was also an increase in p53 protein levels at T ¼ 6 and 8 h in both cell types. It is noted that MCF-7 has wild-type p53 and wild-type Rb genes, while DU-145 contains a single mutant p53 allele encoding a double point mutant p53 protein and a mutant Rb allele with an internal in-frame deletion of exon 21 (Rubin et al., 1991; Wosikowski et al., 1995) . Since BRCA1 protein was similarly lost during heating of both cell types, it is unlikely that the p53 or Rb status of these cell lines was a critical factor in the regulation of BRCA1 protein levels under heat shock conditions. There appeared to be a slight drop in HSP27 levels at T ¼ 2-6 h, and little or no change in the p21 WAF1/CIP1 levels.
To better define the time course for the disappearance of BRCA1 protein in response to heat, time course studies were performed using shorter heating times (at 421C), from T ¼ 20 to 120 min. These studies revealed a significant decrease in BRCA1 protein expression starting at T ¼ 60 min in DU-145 and MCF-7 cells, and strongly reduced levels of BRCA1 protein by TX80 min in both cell types (Figure 2 ). Increases in HSP70 levels were noted starting at T ¼ 20-40 min and reaching maximum values of 1.5 to 2.5-fold during the time interval studied. On the other hand, the effects of heat on HSP27 and HSP90 were relatively modest during this time interval.
Heat treatment fails to downregulate BRCA1 mRNA expression
In contrast to the alterations observed at the protein level, heat shock (10-180 min at 421C) failed to downregulate BRCA1 mRNA levels, as determined by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis (Figure 3 ). On the other hand, the mRNA levels of HSP27 and HSP70 were increased, by up to 2.5-fold (HSP27) and 3.5-fold (HSP70), relative to b-actin as a control for loading. The levels of HSP90 remained unchanged during this time period. These findings indicate that in contrast to HSP70, which increased at both the mRNA and protein levels in response to heat, there was a dissociation between BRCA1 protein (which decreased) vs mRNA expression (which remained unchanged). Thus, the downregulation of BRCA1 in response to heat appears to occur primarily through regulation at the protein level.
Heat treatment downregulates ectopically expressed BRCA1 protein in DU-145 cell clones
The studies described above suggest that the loss of BRCA1 following heat shock is due primarily or exclusively to protein level regulation (i.e., degradation). If this is true, then BRCA1 protein expressed under the control of a constitutive promoter should still be lost following the application of heat shock. To test this hypothesis, we studied stably transfected wild-type BRCA1 (wtBRCA1) and control-transfected (Neo) clones of DU-145 cells, which we had established and Figure 2 Time course for the loss of BRCA1 protein: short time intervals. Assays were performed as described in Figure 1 legend, except that shorter heating intervals were utilized, from T ¼ 20 to 120 min at 421C. Western blots for DU-145 and MCF-7 cells are shown in panels a and b, respectively. Protein quantitation (relative to a-actin) by densitometry is provided in panel c BRCA1 modulates the heat shock response Y Xian et al characterized previously (Fan et al., 1998b) . The wtBRCA1 gene is expressed under the control of the strong CMV promoter in the pcDNA3 vector. Two clones of each type were subjected to heating (2 h at 421C), followed by Western blot analysis. As shown in Figure 4 , BRCA1 protein levels in the nonheated wtBRCA1 clones were significantly higher than in the control (Neo) clones. However, following heat treatment, the BRCA1 protein disappeared in both wtBRCA1 and Neo cell clones. An interesting secondary finding from this experiment was that the HSP27 protein levels appeared to be higher in the wtBRCA1 clones than in the Neo clones, under both heated and nonheated conditions. This did not appear to be the case for HSP70 or for HSP90, although HSP70 levels increased slightly in heated cells, as compared with unheated cells, as observed earlier.
Several repeat experiments gave similar results (data not shown).
Up-regulation of HSP27 expression in wtBRCA1 relative to control (Neo) cell clones As a follow-up to the previous studies, we compared the expression of BRCA1 and several different HSPs in parental DU-145 cells and three clones each of wtBRCA1-and Neo-transfected cells. As expected, the BRCA1 mRNA ( Figure 5a ) and protein ( Figure 5b ) levels were significantly higher in wtBRCA1 clones than in parental cells or Neo clones. Consistent with the results shown in Figure 4 , the HSP27 mRNA and protein levels were also increased in the wtBRCA1 clones, relative to the parental and Neo cells (Figure 5a and b). However, the expression of HSP70 and HSP90, at both the mRNA and protein levels, was similar in the wtBRCA1 clones, relative to the parental and Neo cells. These results suggest that the overexpression of the wtBRCA1 gene is linked to increased expression of the small heat shock protein HSP27, an unexpected finding.
Exogenous BRCA1 activates the HSP27 promoter
We utilized two HSP27 promoter/luciferase reporter constructs (as described earlier by Oesterreich et al., 1997) to determine if exogenous BRCA1 is capable of activating the HSP27 promoter. In transient transfection assays using promoter constructs containing 15-1090 bp and 15-722 bp upstream of the transcription start site of human HSP27, exogenous wtBRCA1 induced (2.1 to 4.1)-fold increases in HSP27-Luc activity in both DU-145 prostate cancer and T47D breast cancer cells (Po0.001) (see Figure 6a ). For this study, we used T47D cells rather than MCF-7 cells, since the latter exhibit a high endogenous level of BRCA1 expression. These findings suggest that in addition to stimulating HSP27 mRNA and protein expression, exogenous wtBRCA1 upregulates the activity of the HSP27 promoter.
To determine the regions of the BRCA1 protein involved in the regulation of HSP27 promoter activity, HSP27 reporter assays were performed using the 15-1090 promoter segment and a set of carboxyl and amino-terminally truncated BRCA1 expression constructs. These constructs have been described before (Fan et al., 2001a, b) . In Figure 6b , the relative HSP27-Luc activity in the presence of each BRCA1 cDNA is expressed as a percentage of the increase in luciferase activity induced by the full-length wtBRCA1. Note that for DU-145 cells, BRCA1 proteins consisting of amino acids 1-302 (D EcoR1), 1-771 (D Kpn1), and 1-1313 (D BamH1) yielded increases in luciferase activity of about 45, 61, and 85% of those induced by wtBRCA1 ( Figure 6b ). (In the experiment shown in Figure 6b , the fold increase in HSP27(15-1090)-Luc activity induced by full-length wtBRCA1 was 4.2-fold for DU-145 ( ¼ 100%) and 2.2-fold for T47D ( ¼ 100%)). When the same assays were performed using amino-terminal BRCA1 truncations 302-1863, 771-1863, and 771-1863 , the percentage increases in luciferase activity were 61, 29, and 5%, respectively (Figure 6c ). These findings suggest that the amino-terminal portion of the BRCA1 protein is sufficient for the induction of HSP27 promoter activity and that the carboxyl-terminus (aa 1313-1863) is dispensable with respect to this activity.
wtBRCA1 protects DU-145 cells against heat shock toxicity
We utilized the MTT assay of cell viability to assess the effect of stable wtBRCA1 overexpression in DU-145 cells on cytotoxicity caused by heat shock. The MTT assay measures the ability of intact (functionally viable) mitochondria to reduce a tetrazolium dye to formazan (Alley et al., 1988) . wtBRCA1 or control (Neo) DU-145 cell clones were subjected to heat treatment at 42 o C for T ¼ 2, 4, or 8 h and then assayed for MTT dye conversion. Based on MTT assays of three clones of each type, the wtBRCA1 clones showed significantly increased cell viability for each heat treatment time interval (Po0.001, two-tailed t-tests) (see Figure 7a ). At T ¼ 2 and 4 h, the viability of wtBRCA1 cells was E30-40% higher than those of the control cells (Po0.001). Several independent repeat experiments gave very similar results.
One of the hallmarks of cellular apoptosis is the fragmentation of nuclear DNA into interoligonucleosomal-sized pieces (Herrmann et al., 1994) . To determine if wtBRCA1 acts to block heat-induced apoptosis, wtBRCA1 and Neo cells were subjected to heat shock (2 h at 421C) and then assayed for DNA apoptotic fragmentation. These assays revealed no evidence of heat-induced DNA fragmentation in either cell type ( Figure 7b ). However, at 24 h after a 2 h exposure to the DNA topoisomerase IIa inhibitor adriamycin, apoptotic DNA ladders were observed in both the Neo and wtBRCA1 cells. Consistent with our previous findings, increased apoptosis (a stronger DNA ladder) was observed in the wtBRCA1 cells (Fan et al., 1998b) . These findings suggest that the overexpression of wtBRCA1 protects DU-145 cells against the rapid heat-induced loss of mitochondrial function. Figure 7a shows an MTT dose response for heatinduced loss of cell viability, in which MTT dye conversion was measured immediately after exposure to heat. To rule out the possibility that exogenous wtBRCA1 merely delays the onset of cytotoxicity and apoptosis in response to heat, cells were exposed to heat (421C Â 2 h) and postincubated at 371C for T ¼ 24 or 48 h prior to harvesting for MTT assays (Figure 7c ). These assays still showed a large increase in the viability of DU-145 wtBRCA1 cell clones, as compared with the control (Neo) clones at both 24 h and 48 h following heat shock (Po0.001, two-tailed t-test). It was observed that the Neo clones showed a continued loss of cell viability from 24 h to 48 h postheating, which was not observed in the wtBRCA1 cell clones. These findings suggest that the heat-induced loss of cell viability continues in the postheating interval but is arrested or retarded by wtBRCA1.
Heat does not induce mitochondrial depolarization or apoptosis
The loss of mitochondrial membrane potential (D) is a hallmark of the mitochondrial apoptosis signaling and is associated with the release of cytochrome c, although Waterhouse et al., 2001) . We used the DePsipher assay to assess mitochondrial membrane potential in DU-145 wtBRCA1 and Neo cell clones following exposure to heat or adriamycin. After an exposure to heat (421C Â 2 h), neither wtBRCA1 nor Neo cells showed any significant loss of mitochondrial membrane potential (see Figure 8a ). However, exposure to ADR induced loss of D (indicated by loss of the punctate extranuclear red staining) in a significant percentage of the cells. Consistent with the increased sensitivity of wtBRCA1 cell clones to ADR (Fan et al., 1998b) , the proportion of ADR-treated wtBRCA1 cells showing loss of D was higher than that of the control (Neo) cells (85 vs 55%, respectively).
We also used the TUNEL (terminal deoxytransferase (TdT) end-labeling) assay to assess apoptosis in heattreated DU-145 wtBRCA1 vs Neo cell clones (Gavrieli et al., 1992) . This assay allows in situ assessment of apoptotic cells by TdT-mediated labeling of fragmented nuclear DNA. As determined by immunofluorescence detection of TdT labeled cells, heating (421C Â 2 h) failed to induce apoptosis (o5% labeled cells) in either a Neo or wtBRCA1 cell clone ( Figure 8b ). In contrast, exposure to ADR caused a significant increase in the percentage of TdT-labeled cells; and the wtBRCA1 clone showed a higher percentage of apoptotic cells than the Neo clone, as expected (Fan et al., 1998b) . Taken together with the DNA ladder, mitochondrial membrane potential, and MTT assays, these studies suggest that heat-induced cytotoxicity in DU-145 cells does not occur through a classical apoptosis pathway. On the other hand, ADR-induced toxicity is due, at least in part, to the induction of apoptosis.
Increased heat sensitivity of Brca1 mutant cells
Studies of cells completely lacking any BRCA1 protein are difficult due to the fact that cells derived from Brca1 null mouse embryos show a severe proliferation defect, associated with the activation of p53 and expression of Figure 6 Exogenous BRCA1 stimulates HSP27 promoter activity. (a) Effect of wtBRCA1 on HSP27-Luc reporter activity. Subconfluent proliferating cultures of DU-145 prostate or T47D breast cancer cells in 24-well dishes were transfected with 0.25 mg of each indicated vector (and pRSV-b-gal), as described in the Methods section. Dishes were incubated for another 24 h, after which the luciferase activity was determined. Luciferase values are expressed relative to the negative control (no reporter) normalized to bgalactosidase activity and are means 7s.e.m.'s of four replicate wells. A second experiment gave similar results. For each reporter plasmid (15-1090 and 15-722) and each cell line, wtBRCA1 induced a significant increase in HSP27-Luc activity: Po0.001, using the two-tailed Student's t-test. (b,c) Effect of protein truncations on BRCA1-mediated stimulation of HSP27-Luc activity. Assays were performed as in panel a, using the HSP27-Luc reporter containing the longer (15-1090) promoter segment and a set of FLAG-tagged carboxyl (b) or amino (c) terminally truncated BRCA1 expression constructs. Luciferase activities were expressed relative to the increse in activity observed for the fulllength wtBRCA1 ( ¼ 100% (Hakem et al., 1996) . However, mouse embryo fibroblasts (MEFs) derived from embryos with homozygous deletions of Brca1 exon 11 do survive and proliferate well in culture, although they exhibit a defect in the DNA damage response (Huber et al., 2001) . The 92 kDa Brca1 D exon 11 protein is produced and shows the proper nuclear localization in these cells (Huber et al., 2001) . To test the effect of the D exon 11 mutation on heat sensitivity, we compared the responses of Brca1 mutant (Brca1
) or control (Brca1 +/+ ) MEFs to exposure to heat (421C Â 2 h or Â 8 h), using the MTT assay ( Figure 9 ). Although the quantitative differences in cell viability were not large, Brca1
DEx11/DEx11 MEFs showed significantly reduced cell viability after heating for 2 h and for 8 h, as compared with Brca1 +/+ MEFs (P o 0.01). These findings are consistent with a role for endogenous Brca1 in maintaining resistance to heat (see Discussion).
Structural requirements for the heat-induced degradation of BRCA1
To determine which region(s) of BRCA1 is (are) required for the rapid heat-induced degradation, DU-145 cells were transiently transfected with expression vectors for different epitope-tagged truncated BRCA1 proteins, subjected to heat treatment (421C Â 2 h), and Western blotted to detect the tag. These studies utilized BRCA1 cDNAs cloned into the pCMV-Tag2 vector, which contains an amino-terminal FLAG tag, as described earlier (Fan et al., 2001b) . Based on FLAG Western blots, full-length wtBRCA1 (aa 1-1863) and a series of carboxyl-terminally truncated FLAG-BRCA1 proteins (BRCA1 aa 1-302, 1-771, and 1-1313) were all well expressed and were fully degraded in response to heat (see Figure 10a ). Amino-terminally truncated FLAG-BRCA1 proteins (aa 302-1863, 771-1863, and 1313-1863) were also expressed in DU-145 cells; but the aa 1313-1863 fragment was not degraded in response to heat (Figure 10b ). Taken together, these findings suggest that several amino-terminal domains of BRCA1 may contribute to the protein degradation; while the carboxyl-terminus of BRCA1 is not required for degradation. These results are further considered in the Discussion.
Protease inhibitors fail to restore BRCA1 protein levels during heat shock Our findings suggest that BRCA1 is rapidly degraded during the heat shock response. So far, the mechanism(s) by which BRCA1 protein is (are) lost during heat shock is unclear, although the above studies suggest that the amino-terminus of BRCA1 controls its degradation. , and 8 h), the viability of the wtBRCA1 cell clones was significantly higher than that of the Neo cell clones: Po0.001, two-tailed Student's t-tests. (b). DNA ladder assays. To determine if the loss of cell viability detected by the MTT was due to apoptosis, one clone each of wtBRCA1 and Neo cells were subjected to heating (421C Â 2 h) and then harvested for DNA fragmentation assays. As positive controls, the same wtBRCA1 and Neo clones were treated with adriamycin (ADR, 15 mM Â 2 h) and then post-incubated in fresh drug-free medium for 24 h, before harvesting for DNA assays. To investigate specific proteolytic pathways that may be involved in the destruction of BRCA1 protein during heating, we tested several protease inhibitors for their ability to block the loss of BRCA1 during heat shock. MG132 is a potent inhibitor of the 26S proteasome, which strongly inhibits the classic ubiquitin/proteasomal degradation pathway (Lee and Goldberg, 1996) . Whether MG132 (10 mM) was present during heat shock (421C Â 2 h) or for 6 h prior to as well as during heat shock, there was no recovery of the BRCA1 protein levels in either DU-145 cells (Figure 11a ) or MCF-7 cells (data not shown). In some experiments, MG132 appeared to cause an increase in HSP70 levels, but these effects were variable. There was little or no effect on HSP27.
We also tested the ability of the protease inhibitor ALLN (N-acetyl-leucyl-leucyl-norleucinal) to block heat-induced BRCA1 degradation in DU-145 cells, either alone or in combination with MG132 (see Figure  11a ). ALLN is a strong inhibitor of calpain and some cathepsins and a weaker inhibitor of other proteases (including the 26S proteasome) (Inoue et al., 1991) . Without or with MG132, ALLN (100 mm concentration) failed to restore the BRCA1 protein levels in heattreated cells. Thus, we were unable to adduce evidence that proteasome and/or calpain inhibitors could prevent the heat-mediated degradation of the BRCA1 protein.
Caspases are activated in the setting of apoptosis and function to cleave key cellular substrates, ultimately resulting in cell death. Similar to MG132, incubation with the pan-caspase inhibitor z-VAD-fmk (100 mm) (Zhu et al., 1995) , alone or in the presence of ALLN, failed to reverse the heat-induced loss of the BRCA1 protein (Figure 11b ). However, in other studies, we found that this dose of z-VAD-fmk is sufficient to inhibit apoptosis induced by the DNA damaging agent adriamycin, by a number of different criteria (data not shown). Ammonium chloride (NH 4 Cl) and chloroquine have previously been found to be lysosomo-trophic agents that can stabilize lysosomes and block protein degradation (Bates et al., 1982; Poole et al., 1997) . We tested the ability of these agents to prevent the heat-induced disappearance of the BRCA1 protein. As shown in Figure 11c , the BRCA1 protein levels were somewhat increased in DU-145 cells that were treated with NH 4 Cl (2.5 mm) but nonheated, suggesting that NH 4 Cl might enhance the basal level of the BRCA1 protein. However, NH 4 Cl did not prevent or reverse the loss of BRCA1 in the heat-treated cells. Similarly, chloroquine (100 mm) did not prevent the loss of BRCA1 protein in heattreated cells (data not shown). Thus, under our experimental conditions, lysosome-stabilizing agents failed to restore BRCA1 protein loss.
BRCA1 does not associate with HSPs in vivo
Since HSPs may associate with various key cellular regulatory proteins and function as chaperones, we performed immunoprecipitation (IP)-Western blotting to determine if BRCA1 physically associates with several HSPs in the absence or presence of heat shock. Subconfluent proliferating DU-145 cells were subjected to heat (T ¼ 0 (control), 0.5, or 3 h at 421C) and immunoprecipitated using BRCA1 antibodies or normal IgG (negative control) (Fan et al., 2001a) . BRCA1 IPs and a nonprecipitated cellular lysate control (for Western blotting technique) were Western blotted to detect BRCA1, HSP27, HSP70, and HSP90. None of the HSPs were detected in the BRCA1 IPs from either heated or nonheated cells (data not shown). Consistent with the straight Western blot assays, IP-Westerns of DU-145 cells showed a reduction in the quantity of BRCA1 precipitated from heated cells, as compared with nonheated cells. As controls, no BRCA1 was detected in an IP performed with control antibody (normal IgG); and all four proteins were detectable in (nonprecipitated) cellular lysates. We cannot rule out the possibility that these assays failed to detect a BRCA1:HSP association because of a technical failure (e.g., the BRCA1 IP antibody disrupts the protein interactions). However, we have been able to detect other BRCA1 protein interactions (e.g., with Rb, cyclin D1, and c-Myc) under similar conditions.
Discussion
Somewhat surprisingly, we discovered that heat treatment of prostate (DU-145) and breast cancer (MCF-7) cells causes the rapid disappearance of BRCA1 protein, starting at E1 h and becoming nearly complete by E2 h at 421C. The loss of BRCA1 occurred at the protein level, since: (1) there were no similar heat-induced alterations of BRCA1 mRNA levels; and (2) BRCA1 protein loss was also observed in DU-145 wtBRCA1 stably transfected cell lines that constitutively overexpressed BRCA1. These findings strongly suggest that the BRCA1 protein is rapidly degraded in response to heat shock. We had previously reported that following certain forms of DNA damage (e.g., those induced by topoisomerase inhibitors adriamycin and camptothecin, or by UV-C light), prostate, breast, and ovarian cancer cells exhibit the downregulation of BRCA1 expression (Andres et al., 1998; Fan et al., 1998a Fan et al., , 1999b .
However, DNA damage-induced downregulation of BRCA1 appears to be distinct from that caused by heat. The former is a prolonged process, characterized by the downregulation of BRCA1 mRNA levels starting at 6-8 h after exposure to DNA damaging agent, and leading to the downregulation of BRCA1 protein levels after X1 day. Thus, DNA damage-induced alterations of BRCA1 levels appear to be due primarily to the inhibition of gene expression. Furthermore, DU-145 cell lines stably transfected with the wtBRCA1 gene were considerably more sensitive to cytotoxicity and apoptosis induced by DNA damaging agents (topoisomerase inhibitors) adriamycin and camptothecin (Fan et al., 1998b) . On the other hand, in this study, we found that the same wtBRCA1-transfected DU-145 cell clones were more resistant to cytotoxicity induced by heat shock (measured using the MTT assay of cell viability), as compared with parental cells or control (Neo)-transfected cell clones.
While exogenous wtBRCA1 decreased the heat sensitivity of DU-145 cells, mouse embryo fibroblasts homozygous for a mutant BRCA1 with a deletion of exon 11 showed a small but significant increase in heat sensitivity, as compared with wild-type fibroblasts. The relatively modest increase in heat sensitivity of the Brca1 DEx11/DEx11 MEFs may owe to the fact that these cells produce an internally deleted form of BRCA1 Figure 9 Increased heat sensitivity in Brca1 mutant mouse fibroblasts compared with wild-type cells. Subconfluent proliferating cultures of mouse embryo fibroblasts (MEFs) derived from Brca1 mutant (Brca1 DEx11/DEx11 ) or control (Brca1 +/+ ) animals were sham-treated or heated (421C Â 2 h or 8 h) and then assayed for cell viability using the MTT assay. Cell viability values are expressed relative to unheated control cells and are means 7 s.e.m.'s of ten replicate wells. Brca1
DEx11/DEx11 showed significantly lower values of cell viability in response to heat for 2 h and 8 h, as compared with Brca1 +/+ cells: Po0.01, two-tailed Student's t-tests BRCA1 modulates the heat shock response Y Xian et al (E92 kDa) that localizes to the nucleus (Huber et al., 2001 ). Thus, it is possible that the D exon 11 deleted Brca1 retains some cytoprotective activity against heat shock, since some truncated BRCA1 proteins retained the ability to activate the HSP27 promoter. Thus, three carboxyl-terminally truncated fragments of BRCA1 each stimulated HSP27 promoter activity, although the smaller fragments gave less stimulation than the larger ones. A carboxyl-terminal fragment of BRCA1 (aa 1313-1863) gave little or no stimulation of promoter activity, suggesting that the carboxyl-terminus is neither necessary nor sufficient to activate the HSP27 promoter. Each of the truncated BRCA1 proteins was FLAGtagged, and Western blots revealed that all of the tagged proteins were expressed. The mechanism by which BRCA1 promotes resistance to heat toxicity is unclear. However, we found that the wtBRCA1 DU-145 clones expressed higher levels of small heat shock protein HSP27 mRNA and protein than control (parental cells or Neo) cells. The levels of other HSPs (HSP70 and HSP90) were similar in wtBRCA1 vs control clones. Recently, several HSPs, including HSP70 and HSP27, were found to protect cells against apoptosis (Guenal et al., 1997; Jaattela et al., 1998; Garrido et al., 1999; Nylandsted et al., 2000b; Pandey et al., 2000; Saleh et al., 2000; Kamradt et al., 2001) . These HSPs appear to function, in part, postmitochondrially, to block the cytochrome c/apoptosis-inducing factor-1 (Apaf-1)-mediated activation of caspase-9, a critical event in the mitochondrial pathway of apoptosis signaling. However, HSPs may also protect cells independently of classic mitochondrial and caspase-dependent cell death pathways (Nylandsted et al., 2000b) . Figure 10 Amino-but not carboxyl-terminus is required for heat-induced degradation of BRCA1. Subconfluent proliferating cultures of DU-145 cells were transiently transfected overnight with expression vectors encoding a series of FLAG-tagged BRCA1 proteins with carboxyl-(a) or amino-terminal (b) truncations (see the Methods section for details). The cultures were sham-treated or exposed to heat (421C Â 2 h), and then harvested for Western blotting using an anti-FLAG vector. FLAG-wtBRCA1 was used as a positive control BRCA1 modulates the heat shock response Y Xian et al
During the a short heating interval (2 h at 421C), there was no significant apoptotic DNA fragmentation (based on agarose gel electrophoresis and TUNEL assay) in wtBRCA1 or control DU-145 cells, even though there was loss of BRCA1 protein and the control cells showed loss of cell viability based on MTT assays. Furthermore, mitochondrial membrane depolarization, an event that occurs during mitochondrial apoptosis signaling, was not observed in heat-treated DU-145 cells. Finally, cell viability of DU-145 wtBRCA1 clones remained . Subconfluent proliferating DU-145 cells were treated 7 heat (421C Â 2 h) and 7 MG132 (10 mm). MG132 was present during the heating or for 6 hr prior to heating as well as during the heating. DU-145 cells were also tested to determine if the caplain inhibitor ALLN (100 mM) could prevent heat-induced disappearance of BRCA1 protein, alone or in combination with MG132. Western blotting was performed to detect BRCA1, HSP27, HSP70, HSP90, and a-actin (control for loading and transfer). (b). z-VAD-fmk. Assays were performed as described above, using the pan-caspase inhibitor z-VAD-fmk, either alone or in comination with ALLN, in DU-145 cells. Note: The inhibitors were applied starting 2 h prior to heat treatment and were present during heating. (c) NH 4 Cl. Assays were performed as above, using 2.5 mm of NH 4 Cl, an agent that stabilizes lysosomal membranes and, thereby, inhibits the lysosomal protein degradation pathway BRCA1 modulates the heat shock response Y Xian et al significantly higher than that of control (Neo) clones (and nearly the same as unheated cells) at 24-48 h postheating, suggesting that exogenous wtBRCA1 can prevent, rather than merely delay, entry into apoptosis. These findings suggest that wtBRCA1 protects DU-145 cells against heat shock through nonapoptotic pathways, although we cannot rule out the possibility that wtBRCA1 inhibits heat-shock-induced apoptotic events prior to DNA fragmentation.
We used FLAG-tagged BRCA1 proteins to assess which region(s) of the BRCA1 protein control its heatinduced degradation. The findings suggest that the carboxyl-terminus of BRCA1 (aa 1313-1863) is heat stable when expressed by itself and is not required for degradation. They also suggest that more than one portion of the BRCA1 protein may mediate its degradation, since mutually exclusive BRCA1 fragments [e.g., aa 1-302 and 302-1863; aa 1-771 and 771-1863) were degraded. At present, it is unclear whether the portions of BRCA1 that are susceptible to heat-induced degradation are: (1) directly targeted for proteolysis (eg., due to specific sequence motifs that become uncovered in heated cells); (2) indirectly targeted through BRCA1-mediated transcription alterations; or (3) a combination of these mechanisms.
Relative to mechanism (1) several motifs that contribute to the degradation of cell-cycle-regulated proteins (e.g., cyclins) have been identified, including the D (destruction) box (RXXLXXXXN) and the KEN box (KENXXX(N/D)) (R ¼ arginine, L ¼ leucine, N ¼ asparagine, D ¼ glutamine, K ¼ lysine, and E ¼ glutamic acid, and X ¼ any amino acid). These sequences target the proteins for ubiquitin-mediated degradation (Fang et al., 1998; Pfleger and Kirschner, 2000) . A search of the BRCA1 aa sequence reveals a KEN-like sequence in the amino-terminus ( 110 KENXXXE) and a D-box motif in the carboxylterminus ( 1726 RXXLXXXD), but the significance of these motifs in BRCA1 is unclear at present. The PEST sequence, that is, a region rich in four amino acids (proline, glutamic acid, serine, and threonine) that is sometimes flanked by postively charged aa residues, is present in a number of proteins with a short half-life (e.g., cyclin F) (Rogers et al., 1986; Fung et al., 2001) . The BRCA1 protein is remarkably rich in these residues (33.2%) and has a number of sites throughout its sequence that could be potential PEST domains. PEST containing proteins are degraded through as yet unidentified mechanisms, although in some cases, the ubiquitin-proteasome pathway and calpain may contribute to their proteolysis.
Since the heat-induced loss of BRCA1 was probably due to protein degradation, we tested the ability of inhibitors of various proteolytic pathways to restore the BRCA1 protein levels. Despite the use of inhibitors at doses known to be effective in other assays, we were unable to block the heat-induced loss of BRCA1 using inhibitors of: (1) the ubiquitin/proteasome pathway (MG132); (2) calpain and some cathepsins (ALLN); (3) caspases (z-VAD-fmk); (4) lysosomal pathways (NH 4 Cl and chloroquine); and (5) combinations of proteolytic pathways. While phosphorylation of the BRCA1 protein in different settings is well documented (Scully et al., 1997b; Thomas et al., 1997; Lee et al., 2000) , relatively little is known about the regulation of BRCA1 expression at the protein level. In a prior study, certain protease inhibitors (ALLN, NH 4 Cl, and chloroquine) were found to prolong the BRCA1 protein halflife in human cancer cell lines with very low basal levels of BRCA1 protein (Blagosklonny et al., 1999) . The authors postulated that degradation of BRCA1 by a cathepsin-like protease balanced new protein synthesis in order to maintain a low steady-state level of BRCA1 protein in these cell types. Our studies render it unlikely that a similar mechanism is involved in BRCA1 degradation during heat shock, since the same three protease inhibitors failed to prevent the loss of BRCA1 caused by heat.
The BRCA1 protein itself has been linked to the ubiquitin-proteasomal degradation pathway, in several studies. For example, a novel ubiquitin carboxylterminal hydrolase, known as BAP1, has been found to interact directly with the amino-terminal RING domain of BRCA1 (Jensen et al., 1998) . BAP1 may contribute to the tumor suppressor activity of BRCA1, although the precise functional consequences of the BRCA1:BAP1 interaction have not been established. In a recent study, it was reported that the RING domain of BRCA1 itself exhibits an E3 ubiquitin protein ligase-like activity (Ruffner et al., 2001) . In this study, cancerassociated mutations of the BRCA1 RING domain abolished the E3-like activity and the ability to reverse the hypersensitivity to ionizing radiation in BRCA1 null cells. Finally, a cancer-associated mutation of the BRCA1 RING finger disrupted the ability of a 110 kDa amino-terminal protease-resistant BRCA1 fragment to homodimerize in solution and increased the proteolytic susceptibility of this fragment (Brzovic et al., 1998) . These observations suggest that the amino terminus of BRCA1, including the RING domain, may control the susceptibility of BRCA1 and, perhaps, BRCA1-associated proteins, to degradation, by an as yet, unidentified mechanism(s).
Since HSPs function as chaperones to maintain the stability of or prevent the mis-folding of key cellular regulatory proteins, we tested the possibility of a BRCA1:HSP protein interaction by IP-Western blotting. Despite the ability to successfully immunoprecipitate BRCA1 and demonstrate other in vivo BRCA1 protein interactions (Fan et al., 2001a, b) , we were unable to detect any in vivo association of BRCA1 with HSP27, HSP70, or HSP90 in DU-145 cells. These findings do not rule out the possibilities that (1) technical problems could account for the failure to detect a BRCA1 interaction with HSPs; or (2) BRCA1 can interact with a number of other HSPs that we did not test.
Another possibility to consider is that heat causes a conformation change in the BRCA1 protein resulting in the failure of the BRCA1 antibodies to detect the altered protein structure. Such a conformational alteration would presumably have to differ significantly from that BRCA1 modulates the heat shock response Y Xian et al induced by the relatively harsh lysis buffer (RIPA), boiling in sample buffer, and electrolytic protein transfer, which did not affect the BRCA1 detection in nonheated cells or the detection of variety of other proteins in nonheated and heat cells. We addressed this issue by testing two different BRCA1 antibodies: (1) C-20 (an antibody raised against a peptide corresponding to the carboxyl-terminal 20 amino acids of BRCA1); and (2) a combination of three monoclonals (Ab-1+Ab-2+Ab-3) reactive against epitopes in the amino-and carboxyl-termini of BRCA1. Both antibody preparations detected BRCA1 in nonheated cells but not in heated cells. Furthermore, it is noted that the C-20 antibody was raised against a small peptide sequence, and should, therefore, not be very sensitive to protein configurational changes. Along these lines, it is also possible that heat induces an alteration in the subcellular distribution of the BRCA1 protein into a compartment that renders it inaccessible to the BRCA1 antibody, even after lysis using RIPA buffer; or BRCA1 could become associated with RIPA-insoluble cellular components. We cannot rule out these possibilities based on our studies. However, even allowing that heat may somehow alter the localization of BRCA1 so that its antigenic determinants cannot be detected, this would not negate the likelihood of a role for the BRCA1 protein in the heat shock response, since such heat-induced alterations of the BRCA1 localization would be likely to have physiological consequences. Thus, immediately (within o1 h) following exposure of cells to DNA damaging agents, the BRCA1 protein becomes hyperphosphorylated and translocates to distinct nuclear foci containing other DNA damage-linked proteins (e.g., PCNA, Rad51, BRCA2) (Scully et al., 1997b; Thomas et al., 1997; Lee et al., 2000) . These events are thought to be linked to the function of BRCA1 in DNA damage signaling and repair; but they are not associated with a loss of BRCA1 protein or antigenicity.
The finding of enhanced resistance to the heatinduced loss of cell viability as well as the upregulation of expression of HSP27 in wtBRCA1 overexpressing DU-145 cells is a further evidence suggesting a role for the BRCA1 protein in the heat shock response. As cited above, HSP27 exhibits an antiapoptotic function, although this function is unlikely to account for the wtBRCA1-mediated resistance to heat stress. In response to various stresses, it has been found that HSP27 becomes phosphorylated and aggregates into supramolecular structures of up to several megadaltons (Benndorf et al., 1994; Bruey et al., 2000) . Recently, several studies have documented that ectopic overexpression of HSP27 and several related proteins-a Bcrystallin (a small HSP of the vertebrate lens) and hspA (a small HSP of cyanobacteria)-rendered the host cells thermotolerant or resistant to hyperthermia (Aoyama et al., 1993; Trautinger et al., 1997; Nakamoto et al., 2000) .
These observations may be consistent with our findings that wtBRCA1-transfected DU-145 cells overexpress HSP27 and are thermoresisant, although the linkage of thermoresistance to the BRCA1-mediated upregulation of HSP27 remains to be proven. In heated cells, BRCA1 levels declined rapidly, while HSP27 levels remained high, indicating differential regulation of BRCA1 and HSP27 by heat. Our findings suggest that if HSP27 contributes to the thermoresistance of the DU-145 wtBRCA1 cell clones, it is sufficient that HSP27 protein levels are elevated at the time the heating begins; and mechanisms unrelated to BRCA1 act to maintain the protein levels of HSP27 during heating. Several additional studies have also suggested roles for HSP27 in the regulation of cell differentiation, cell proliferation, and actin polymerization (Miron et al., 1991; Benndorf et al., 1994; Mairesse et al., 1996; Horman et al., 1999) . For example, HSP27 regulated the process of F actin polymerization in biochemical assays, depending upon the degree of phosphorylation and oligomerization of the HSP27 protein (Miron et al., 1991; Benndorf et al., 1994) . These considerations suggest the possibility that HSP27 mediates some of the phenotypic consequences of ectopic BRCA1 expression, which may not just be limited to heat responses.
In conclusion, we showed that BRCA1 can regulate, and in turn be regulated by, the heat shock response in prostate and breast cancer cells. These findings suggest that BRCA1 may play a role in preserving the proteome and promoting cell survival in the setting of heat and other stresses that cause protein unfolding. A BRCA1 function in the maintenance of genomic integrity is widely suspected (Scully et al., 1997b; Tirkkonen et al., 1997; Gowen et al., 1998; Moynahan et al., 1999; Huber et al., 2001) . Since chaperones have been implicated in protein remodeling events that occur during chromosomal replication (reviewed in Jolly and Morimoto, 2000) , it is possible that the function of BRCA1 in genomic maintenance extends beyond its established roles in certain highly specialized forms of DNA repair (i.e., transcription-coupled and homology-directed DNA repair) (Gowen et al., 1998; Moynahan et al., 1999) . Interestingly, BRCA1 was found to interact with STAT1 and to mediate expression of target genes of the immune modulator interferon-g (Ouchi et al., 2000) . Recent studies suggest that mild hyperthermia may enhance the antiviral and antiproliferative activity of interferon-g (Payne et al., 2000) . However, the significance of a BRCA1 function in the heat shock response remains to be proven.
Materials and methods
Reagents
Adriamycin (doxorubicin hydrochloride) was obtained from the Sigma Chemical Co. (St Louis, MO, USA). MTT dye (thiazotyl blue) was obtained from Sigma.
Protease inhibitors
The following agents were used to investigate the mechanism of heat-induced disappearance of the BRCA1 protein: MG132 (a cell permeant 26S proteasome inhibitor) (Cat. 
Cell lines
The cell lines used in this study were originally obtained from the American Type Culture Collection and cultured as described before (Fan et al., 1998b (Fan et al., , 2001a . The production and characterization of stable wtBRCA1-and empty vector (Neo)-transfected DU-145 cell clones were described earlier (Fan et al., 1998b) . Cells were grown in Dulbecco's modified Eagles's Medium (DMEM) supplemented with 5% v/v (DU-145) or 10% v/v (MCF-7) fetal calf serum, l-glutamine (5 mm), nonessential amino acids (5 mm), penicillin (100 U/ml), and streptomycin (100 mg/ml) (all obtained from BioWhittaker, Walkersville, MD, USA).
Expression vectors and transfections
BRCA1. The original wild-type BRCA1 expression plasmid (wtBRCA1) was created by cloning the full-length BRCA1 cDNA into the pcDNA3 vector (Invitrogen) using artificially engineered 5 0 HindIII and 3 0 NotI sites. Expression vectors for different carboxyl or amino-terminally truncated BRCA1 proteins, each containing an amino-terminal FLAG epitope tag, were described previously (see Fan et al., 2001a, b) . These (302-1863 (302- , BRCA1 (771-1863 , and BRCA1 (1313-1863)) were created by cloning the appropriate BRCA1 cDNA into the multicloning site of plasmid pCMV-Tag2 (Stratagene).
Transient transfections. To study the structural determinants of heat-induced BRCA1 protein degradation, subconfluent proliferating cultures of DU-145 cells in 100 mm plastic dishes were transfected overnight with FLAG-tagged truncated BRCA1 expression vector (10 mg of plasmid per 100 mm dish) using Lipofectamine (Gibco-BRL), washed to remove the excess Lipofectamine, and incubated in fresh culture medium for another day to allow recovery of the cells. Cultures were then subjected to heat treatments and Western blotting, as described below.
HSP27-Luc reporter assays. Two HSP27 promoter-luciferase reporter constructs [15-722 and 15-1090 (Oesterreich et al., 1997) ]. The majority of the basal promoter activity is found in the most proximal 200 bp of the promoter. HSP27 promoter activity was determined as follows. Subconfluent proliferating cells in 24-well dishes were transfected overnight using Lipofectamine, with 0.25 mg of each of the following plasmids:
(1) one of the above HSP27-Luc reporters; (2) wtBRCA1 or a FLAG-tagged truncated BRCA1 expression vector or empty vector; and (3) control plasmid pRSV-b-gal (see Fan et al., 2001b) . In each experiment, the total transfected DNA content was maintained constant using the appropriate quantity of empty vector, when required. After transfections, dishes were washed to remove the excess Lipofectamine and vectors and postincubated for another 24 h before harvesting for luciferase and b-galactosidase assays. Luciferase values were expressed relative to negative controls (no reporter) or positive controls (+HSP27(15-1090)-Luc+wtBRCA1) as described in the text and figure legends; and the values were normalized to b-galactosidase activity to control for transfection efficiency. 
Semiquantitative RT-PCR analysis
The mRNA expression of several different gene products (BRCA1, b-actin, and several different HSPs: HSP27, HSP70, and HSP90) were evaluated by semiquantitative RT-PCR assays, as described before (Fan et al., 1998b (Fan et al., , 1999c . The PCR primer sets utilized in this study are shown in Table 1 . The PCR reaction conditions were individually optimized for each gene product studied. For each gene product, the cycle number Table 2 . The b-actin gene was utilized as a control for loading. PCR products were analyzed by electrophoresis through 1.2% agarose gels containing 0.1 mg/ ml of ethidium bromide; and the gels were photographed under ultraviolet illumination. The amplified cDNA product bands were quantitated by densitometry.
Western blotting
Following heat shock or sham treatment, subconfluent proliferating cells in 100 mm plastic Petri dishes were harvested, and whole cell lysates were prepared, as follows. Cells were washed using ice-cold phosphate-buffered saline (PBS), collected using a rubber policeman, and lysed using 150 ml of lysis buffer per 100 mm dish. The lysis buffer was composed of RIPA buffer (1 Â PBS, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) to which was added a commercial protease inhibitor cocktail [Cocktail I, Cat. No. 539131, Calbiochem, La Jolla, CA, USA] at 1 : 100 dilution, immediately prior to use. The lysate was mixed gently by pipetting, incubated at 01C for 30 min, and then centrifuged at 10 000 Â g at 41C for 20 min. The supernatant was saved as the total cell lysate. Equal aliquots of total protein (50 mg per lane) were electrophoresed on 4-13% SDS-polyacrylamide gradient or 15% SDS-polyacrylamide gels, transferred to nitrocellulose membranes (Millipore, Bedford, MA, USA), and blotted using the primary antibodies and antibody dilutions listed above. Details are provided elsewhere (Fan et al., 1998b (Fan et al., , 1999c (Fan et al., , 2001a . Proteins were visualized using the enhanced chemiluminescence system (Amersham Life Sciences, Buckinghamshire, UK), with colored markers (BioRad Laboratories, Hercules, CA, USA) as size standards. Where appropriate, the protein bands were quantitated by densitometry and expressed relative to the 46 kDa a-actin band as a control for loading and transfer.
Immunoprecipitation (IP)
For IPs, subconfluent proliferating cells in 150 cm 2 dishes were harvested, and nuclear extracts were prepared, as described before (Fan et al., 2001a) . Each IP was carried out using 6 mg of antibody or antibody combination and 1000 mg of nuclear extract protein. Precipitated proteins were collected using protein G beads, washed, eluted in boiling Laemmli sample buffer, and subjected to Western blotting. The BRCA1 IP antibody was as a combination of Ab-1 (MS110, Cat. #OP92)+Ab-2 (MS13, Cat. #OP93)+Ab-3 (SG11, Cat. #OP94), mouse monoclonals, Oncogene Research Products/Calbiochem (La Jolla, CA, USA). Ab-1 and Ab-2 are reactive against epitopes in the Nterminus of BRCA1; while Ab-3 is reactive against a C-terminal epitope. A control IP was carried out along with the BRCA1 IPs, using normal mouse IgG. Western blotting of precipitated proteins was carried out as described above.
MTT assay of cell viability
MTT assays of cell viability were performed as described before (Alley et al., 1988; Fan et al., 1998b) . This assay is based on the ability of intact mitochondria cells to convert MTT, a soluble tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide) into an insoluble formazan precipitate, which is quantitated by spectrophotometry following its solubilization in dimethyl sulfoxide. Briefly, subconfluent proliferating cells in 96-well dishes were treated with heat shock at 421C in standard growth medium and then solubilized. Absorbance readings were taken using a Dynatech 96-well spectrophtometer. The amount of MTT dye reduction was calculated based on the difference between absorbance at 570 and 630 mm. Cell viability was expressed as the amount of dye reduction relative to that of nonheated control cells.
Apoptosis assays
DNA fragmentation. Subconfluent exponentially proliferating cells in 100 mm plastic Petri dishes were treated without or with heat (421C) in standard growth medium and then counted. Samples were normalized by cell number (500 000-750 000 cells); and the low molecular weight apoptotic DNA was extracted, as described before (Herrmann et al., 1994; Fan et al., 1998b) . The DNA was electrophoresed through 1.2% agarose gels containing 0.1 mg/ml of ethidium bromide; and the gels were photographed under ultraviolet illumination.
TUNEL. Terminal deoxytransferase (TdT) staining (TU-NEL assay) to detect apoptotic cells was performed using the In Situ Cell Death Detection Kit (Boehringer Mannheim), according to the manufacturer's instructions. This assay allows in situ visualization of apoptotic cell nuclei through nick end labeling of fragmented DNA using TdT (see Gavrieli et al., 1992) . For each cell line and experimental condition tested, at least two separate determinations of the percentage of cells showing TdT fluorescent staining were made. For each determination, at least 400 cells were counted.
Mitochondrial membrane potential. Mitochondrial membrane potential was assessed using DePsipher Assay kits, as per the manufacturer's instructions (R & D Systems, Minneapolis, MN, USA). Briefly, cells were harvested, counted, and washed twice with PBS. The cell pellets corresponding to 1 Â 10 6 cells per assay were then incubated with 1.0 ml of DePsipher solution at 371C for 15 min and re-suspended in 0.5 ml of reaction buffer. The cells were observed immediately by fluorescence microscopy, using a Nikon UFX-II microscope with bandpass filters for fluorescein and rhodamine. In healthy cells, the mitochondria appear red following aggregation of the DePsipher within the mitochondria. The red aggregates emit visible light at 590 nm. In dying cells or cells with disrupted mitochondrial membrane potential, the dye remains in its monomeric form in the cytoplasm and will appear green with an emission wavelength of 530 nm. For each cell line and experimental condition tested, at least two separate determinations of the percentage of cells showing loss of mitochondrial membrane potential were made. For each determination, at least 400 cells were counted.
Data Analysis
Plotted values are expressed as means 7 standard errors of the mean (s.e.m.s), where appropriate, statistical comparisons were made using the two-tailed Student's t-test. 
